CASE 1
New technology go-to- market
Brilliant technologies often struggle to reach the market because of the complexity of turning science into a scalable, structured, and investable business.
At Bespoke Biotech Advisory (BBA), we work at this exact intersection: helping companies bridge the gap between R&D, strategy, and execution.
We will share real case histories that show how we support biotech and medtech companies in:
• Structuring go-to-market strategies
• Navigating regulatory and validation pathways
• Aligning vision, resources, and execution
This first case highlights how we supported a company to turn innovation into tangible market impact.
Swipe through to discover the approach, the challenges, and the results.
LifeSciences Biotech MedTech GoToMarket Innovation BusinessStrategy Execution
CASE 2
Translating high-potential, scientifically strong concepts into high-growth business ventures
We drive efficiency and compliance across all key stages, advancing lab projects into attractive, fundable ventures. Our highly experienced project team, with BBA playing a key role, successfully streamlined and accelerated the time-to-market.
👉 Swipe through to discover the approach, the challenges, and the results.
#techtransfer #healthcare #biotech #gotomarket
#strategy #training
CASE 3
M&A Evaluation under time pressure
In complex, high-stakes decisions, seniority makes the difference.
When time is limited and data is incomplete, experience is what allows you and your team to focus on what truly matters. In this recent case, our senior team supported a rapid M&A evaluation in the diagnostics/IVD space, going beyond the surface of a well-structured business plan to uncover the real drivers of value and risk. The outcome? A clear, evidence-based decision, made in just a few days.
Swipe to see how we approach critical decisions when there is no room for error.
LifeSciences Diagnostics MedTech Strategy DueDiligence Leadership